This systematic review examines the impact of sustained low-efficiency dialysis or continuous renal replacement therapy on patient outcomes in critically ill patients with acute kidney injury. Meta-analysis indicated no statistically significant difference in the primary outcome of overall renal recovery (risk ratio 0.87, 95% confidence interval 0.63-1.20, I2 66%). There appears to be no clear advantage for continuous renal replacement in the haemodynamically unstable patient; however, there may be a mortality benefit for sustained low-efficiency dialysis. Currently, both modalities are safe and effective means of treating acute kidney injury in the critically ill adult.
SUMMARY AT A GLANCE
This systematic review examines the impact of sustained low-efficiency dialysis or continuous renal replacement therapy on patient outcomes in critically ill patients with acute kidney injury. Meta-analysis indicated no statistically significant difference in the primary outcome of overall renal recovery (risk ratio 0.87, 95% confidence interval 0.63-1.20, I2 66%). There appears to be no clear advantage for continuous renal replacement in the haemodynamically unstable patient; however, there may be a mortality benefit for sustained low-efficiency dialysis. Currently, both modalities are safe and effective means of treating acute kidney injury in the critically ill adult.
ABSTRACT:
Critically ill adults with acute kidney injury (AKI) experience considerable morbidity and mortality. Controversy remains regarding the optimal renal replacement intervention for these patients. Our systematic review aimed to determine the effect(s) of sustained low-efficiency dialysis (SLED) compared with continuous renal replacement (CRRT) therapy on relevant patient outcomes. A systematic search of Medline, Embase, CINAHL and the Cochrane Library was conducted. Identified citations were screened independently in duplicate for relevance, and the methodological quality of included studies was evaluated. Data were extracted on study, patient and intervention characteristics and relevant clinical outcomes. Results were pooled using inverse variance fixed and random effects meta-analysis. A total of 1564 patients from 18 studies were included. Meta-analysis results indicated no statistically significant difference in our primary outcome, overall proportion of renal recovery (risk ratio (RR) 0.87, 95% confidence interval (CI) 0.63-1.20, I2 = 66%). No significant difference was observed for the secondary outcome of time to renal recovery (mean difference 1.33, 95% CI 0.23-2.88, I2 = 0%). Statistically, SLED was marginally favoured over CRRT for the secondary outcome of mortality (RR 1.21, 95% CI 1.02-1.43, I2 = 47%); however, this diminished when sensitivity analysis of only randomized controlled trials was conducted (RR 1.25, 95% CI 1.00-1.57, I2 = 0%). There appears to be no clear for advantage continuous renal replacement in the hemodynamically unstable patient. Currently, both modalities are safe and effective means of treating AKI in the critically ill adult.
INTRODUCTION
Acute kidney injury (AKI) is a significant contributing factor to the morbidity and mortality of critically ill adults. 1, 2 There are various modalities of in-hospital renal replacement therapies (RRT) that are in use today, but the critically ill patient imposes the additional challenge of serious haemodynamic instability, which limits RRT options. The advent of continuous RRT (CRRT) permitted the treatment of haemodynamically unstable AKI with tolerance for ultrafiltration, excellent control of azotemia and potentially less ongoing or repeated renal ischaemia. The introduction of sustained low-efficiency dialysis (SLED), which utilizes lower flow rates than conventional intermittent haemodialysis (IHD), improves convenience by restricting therapy time while still allowing for a similar haemodynamic tolerability to CRRT. Additionally, SLED is operationalized with IHD equipment and does not require pre-packaged replacement solution(s). Cost savings thus accrued has resulted in the promotion of SLED utilization in many centers. 3 Nevertheless, there exists a lack of consensus regarding the optimal RRT modality for critically ill patients. Specifically, SLED has not been universally accepted in part because of lack of evidence for haemodynamic tolerability in specific populations with AKI and shock. 4 It has been suggested that the haemodynamic stability-associated CRRT compared with IHD may result in a higher renal recovery rate 5 ; however, few data exist for a comparison of renal recovery with SLED.
We conducted a systematic review and meta-analysis to determine the effect of the mode of dialysis (SLED vs CRRT) on the likelihood of renal recovery in critically ill adults. Our secondary outcomes were to determine the effect of SLED versus CRRT on time to renal recovery, haemodynamic stability/vasopressor use, hypotension and mortality.
METHODS
This systematic review was conducted in accordance to the preferred reporting items for systematic reviews and metaanalysis framework. 6 Inclusion/exclusion criteria English language studies that compared any form of SLED/extended daily dialysis/prolonged intermittent renal replacement to CRRT in haemodynamically unstable adults (≥18 years of age) admitted to the ICU with new-onset AKI requiring RRT were included. Both randomized and nonrandomized studies were included and could be of any published format (e.g. conference abstract, full manuscript). Patients with established dialysis needs were excluded, as were those who received IHD as the initial treatment of their AKI. Literature reviews, systematic reviews, commentaries, case studies, pharmacological studies and physiological studies that did not focus on patient comparisons were also excluded.
Literature search
The search strategy was designed by an information specialist using a combination of controlled vocabulary (e.g. kidney failure, intensive care units) and keywords (e.g. extended dialysis, critical care, SLED). Vocabulary and syntax were adjusted to allow for searching on Medline (1946 onwards), Embase (1947 onwards), CINAHL (1982 onwards) and the Cochrane Library (available through Wiley) on 22 February 2015. There were no language or date restrictions on these searches. Please see File S1 for search strategies. Additional studies were identified by hand searching the bibliographies of included studies and pertinent reviews.
Screening
Two reviewers independently assessed all citations identified by the search strategy for inclusion. At a title and abstract level, this was carried out using a liberal accelerated method, 7 while assessment at the full-text level required consensus on article inclusion. Disagreements were resolved by discussion.
Data extraction
Data were extracted on general study characteristics (e.g. year of publication, country of origin, study design, sample size), demographics (e.g. patient age, gender, APACHE score, SOFA score) and intervention design (e.g. mode of dialysis, flow rates, filtration rates). Extracted outcome variables included the primary outcome of number of patients with renal recovery, and second outcomes of mortality, days to renal recovery, duration of dialysis and complications (a composite outcome including increased vasopressor use, filter clogging, bleeding, line sepsis and increased haemodynamic instability). All data were extracted by one reviewer and verified by a second investigator with all discrepancies resolved through discussion.
Quality assessment
Internal validity of included studies was assessed using tools endorsed by the Cochrane Handbook ; randomized controlled trials (RCT) were assessed using the Cochrane Risk of Bias Tool 9 while non-randomized studies were assessed using the Newcastle Ottawa scale. 10 Disagreements were resolved by consensus.
Data analysis
The primary outcome of our analysis was the proportion of patients who recovered renal function (defined as not requiring RRT). Secondary outcomes included time to renal recovery, haemodynamic stability/vasopressor escalation (any increase in vasopressors dose from baseline prior to initiation of RRT), hypotension (blood pressure drop of >20 point from baseline or <90 systolic) and mortality. Meta-analysis of the data was conducted using random effects models for I 2 greater than 30% and fixed effects models for I 2 less than 30% in Review Manager, 11 and results were visualized through forest plots. Count data were expressed as summary risk ratio (RR) and 95% confidence intervals (CI), while continuous data was expressed as weighted mean difference (MD) and 95% CI. Statistical heterogeneity of the included studies was assessed using the I 2 test, and publication bias was determined using visual examination of the funnel plot. Sensitivity analysis for RCT was conducted for all outcomes, when possible. Subgroup analysis was conducted for different patient populations (survivors or all included patients), patient locations (ICU or hospital) and follow up days (e.g. 30 day mortality).
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RESULTS
Our literature search identified 374 articles; following deduplication, 236 unique articles were screened for inclusion. While 20 studies met a priori inclusion/exclusion criteria, one study was a published correction, 12 and one was a companion, 13 resulting in a total of 18 studies included in the systematic review 3,14-30 ( Fig. 1 ). Studies originated from 11 different countries, with the majority being conducted in Asia (n = 8, 44%) or North America (n = 5, 28%) ( Table 1 ). Relatively few studies were RCT (n = 4, 22%) and were published as a full manuscript (n = 12, 67%) or conference abstract (n = 6, 33%). They examined a total of 1564 patients of which 738 were treated with some form of CRRT, and 826 were treated with some form of SLED ( Table 1 ). The mean patient age of all included studies was at least 45 years, but the majority were >60 years old; patients had mean study-level APACHE II score ranging from 17.3 ± 5.4 to 32.2 ± 7.8; SOFA scores ranging from 7.5 ± 2.9 to 14.2 ± 4.2; and SAPSII scores ranging from 38.1 ± 12.0 to 69.5 ± 14.0. Dialysis flow rates were most often between 100 and 350 mL/h, and blood flow rates were primarily between 100 and 200 mL/min (Table 1) .
Quality assessment
While the majority of non-randomized comparative studies were assessed to have reasonable quality for the selection category of the Newcastle-Ottawa scale, the comparability and outcome category were variable (Table 1) . Only three studies 18, 19, 21 of the 14 included studies were awarded any stars concerning comparability of cohorts, with only one study receiving a perfect score of two stars. 19 Within the outcome category, very few studies reported a sufficient follow up period for the outcome of interest, and only half adequately reported on follow up rates (Table S1 ). Overall scores for outcome were typically low, with the majority of studies receiving two stars or less. Unexpectedly, conference abstracts were often of comparable methodological quality to full manuscripts (Table 1) . Randomized controlled trials showed some consistencies in their reporting (Table 2) . Allocation concealment was not described in any of the four included RCT and therefore was assessed to be of an unclear risk of bias. The lack of blinding of participants and personnel in all studies was judged to be of high risk, as this could influence patient management and cointerventions. Any missing data observed in the studies were Fig. 1 Preferred reporting items for systematic reviews and meta-analysis (PRISMA) flow diagram. EDD, extended daily dialysis; EDHF, extended daily haemofiltration; NOS, Newcastle-Ottawa scale; NR, not reported; O, outcome; PRITT, prolonged intermittent renal replacement therapy; S, selection; SAPS, simplified acute physiology score; SD, standard deviation; S-HDF, sequential haemodiafiltration; SLED, sustained low efficiency dialysis; SOFA, sequential organ failure assessment
Renal recovery with SLED vs CRRT
Renal recovery with SLED vs CRRT adequately addressed, and all expected outcomes were reported, resulting in a low risk of bias for the items of incomplete outcome data and selective reporting. Half of the studies were appropriately randomized and were of low risk of bias for sequence generation. Half also indicated a lack of blinding in outcomes assessors, which was judged to be a high risk as it potentially allowed for the introduction of bias in outcome measurements. Finally, it was unclear whether there were other sources of important bias within the studies.
Primary outcome: renal recovery
Meta-analysis of the five studies 14, 15, 17, 29, 30 that assessed renal recovery showed a high degree of statistical heterogeneity and found that there was no statistically significant difference between CRRT and SLED (RR 0.87, 95% CI 0.63 to 1.20, I 2 = 66%, P = 0.39) (Fig. 2) . However, sensitivity analysis of the two RCT that reported this outcome indicated a significant difference, favouring CRRT (RR 0.68, 95% CI 0.51 to 0.92, I 2 = 0%, P = 0.01) (Fig. 3) .
When subgroup analysis was conducted based on the patient population (all patients or only survivors) and location (ICU or ward), statistical heterogeneity improved to 0% (Fig. 4) . Additionally, CRRT was associated with a significant benefit for in-hospital 14, 15 [14] [15] [16] 23 : RR 0.94, 95% CI 0.8 to 1.11, I 2 = 0%, P = 0.47; ICU 14, 15 : RR 0.68, 95% CI 0.45 to 1.01, I 2 = 0%, P = 0.05) ( Fig. 3 ; Figs S1-S4). Within subgroups, an additional sensitivity analysis of RCT was only needed for the outcome of in-hospital renal recovery of survivors (all other subgroups only consisted of RCT), which remained non-significant (RR 0.67, 95% CI 0.67 to 1.04, I 2 = 0%, P = 0.11) (Fig. S5) . Publication bias could not be assessed because of an insufficient number of studies. Fig. 2 Renal recovery in all patients treated with continuous renal replacement therap (CRRT) versus sustained low-efficiency dialysis (SLED). (Fig. 7) .
Sensitivity analysis using only the four included RCT resulted in borderline statistical significance favouring SLED (RR 1.25, 95% CI 1.00-1.57, I 2 = 0%, P = 0.05) (Fig. 8) . Subgroup meta-analysis for 30 day mortality [14] [15] [16] [17] 26, 30 also significantly favoured SLED (RR 1.36, 95% CI 1.06 to 1.75, I 2 = 0%, P = 0.02); however, subgroups based on location (hospital 3, 14, 15, 19, [22] [23] [24] 27, 28 or ICU 14, 15, 27, 30 ) revealed a nonsignificant difference (hospital: RR 1.12, 95% CI 0.9 to 1.4, I 2 = 56%, P = 0.32; ICU: RR 1.44, 95% CI 0.93 to 2.24, I 2 = 56%, P = 0.1) ( Fig. 9; S6-S8 ). Sensitivity analysis of subgroups supported the lack of a statistically significant difference between locations (hospital: RR 1.35, 95% CI 0.85 to 2.16, I 2 = 37%, P = 0.21; ICU: RR 1.12, 95% CI 0.85 to 1.48, I 2 = 29%, P = 0.42) (Figs S9-S10). However, it also contradicted subgroup meta-analysis results for 30 day mortality, indicating no statistically significant difference between groups (R 1.71, 95% CI 10.95 to 3.11, I 2 = 0%,
Secondary outcome: hypotension
Outcomes relating to hypotension, including hypotension resulting in discontinuation of treatment, 15 number of patients with hypotension during dialysis 29 and number of hypotensive episodes, 27 showed no statistically significant differences between CRRT and SLED. Further, Chen et al. 17 reported no cases of severe intra-dialytic hypotension in either group. Only one study showed a slight preference for CRRT relating to transient attacks of hypotension (CRRT: n = 1/40, 2.5%; SLED: n = 2/40, 5%) 16 ; however, the statistical significance was not evaluated. Finally, one study evaluated hypotension solely in SLED patients, and thus, no conclusions could be made comparing CRRT with SLED. 3 
Secondary outcome: haemodynamic instability/vasopressor use
Haemodynamic instability and vasopressor use were fairly consistent between CRRT and SLED groups. Of the six papers 3, 15, 19, 22, 23, 27 and two abstracts 18, 20 that evaluated this outcome, three studies were not able to show a statistically significant difference in haemodynamic instability for the outcomes of initiation of vasopressor support, 15 vasopressor dose 27 and number of sessions with haemodynamic instability/vasopressor escalation. 19 Two papers 22, 23 and two abstracts 18, 20 favoured SLED compared with continuous veno-venous haemofiltration for average number of ; however the latter outcome was not evaluated for statistical significance. 22 The final paper failed to evaluate haemodynamic outcomes for the CRRT group, and thus, no conclusions could be made. 3 
DISCUSSION
We completed this meta-analysis with the intent of determining if evidence exists regarding the effects of SLED and CRRT on the proportion of critically ill adults achieving renal recovery. Given the economy of SLED, it has gained popularity in many centers, and as such, data concerning its efficacy for renal recovery should also be examined.
The results of our meta-analysis indicate that no one modality (CRRT vs SLED) was superior concerning likelihood of renal recovery and time to renal recovery. This is hypothesized to be due to the similarity between these modalities in terms of physiologic and haemodynamic alternations in patients. For example, both CRRT and SLED maybe be run continuously for 24 h if needed with similar fluid balance. Additionally, it is possible that no difference was observed as the only variable that may influence renal recovery is hypotension, which was not different in the two groups. It must also be noted that sensitivity analysis of only RCT produced contrasting results, significantly favouring CRRT for renal recovery in all patients. This highlights the influence of study design on resulting data and potentially demonstrates how selection and allocation bias, common to observational studies, can affect outcomes. While significant differences were observed in the secondary outcome of mortality following meta-analysis, sensitivity analysis of RCT could only confirm a borderline statistical significance favouring SLED with a P value of 0.05. Our systematic review demonstrated similar results to a recently published review by Zhang et al., 31 in which sensitivity analysis of observational studies indicated a lower mortality risk for SLED compared with CRRT, while pooling of RCT data showed no difference in mortality rates. It is probable that this trend is due to selection bias that may be present in observational studies, where sicker patients are more likely to receive CRRT compared with SLED. Haemodynamic instability and vasopressor use are important contributors to morbidity and mortality. Frequency and duration of episodes of instability and details regarding vasopressor use were not universally reported; however in the six papers and two abstracts that did evaluate these outcomes, no statistical difference could be detected between SLED and CRRT. This Only two studies reported on time to renal recovery and meta-analysis results were unable to establish a statistically significant difference between modalities. A shorter recovery time and fewer dialytic treatments are clearly advantageous, to both the patient and the healthcare system through reduced costs.
LIMITATIONS AND FUTURE DIRECTIONS
There are several limitations to our systematic review. Only English language articles were included in our analysis, and as a result, there is a potential that we excluded relevant articles published in other languages. Additionally, the majority of our studies were observational and retrospective in their study design, allowing for the introduction of error due to confounding, allocation and selection bias. The potential influence of study design on results could be seen through the often-contrasting conclusions of sensitivity analysis of RCT, when compared with the original meta-analysis. We also allowed for the inclusion of abstracts, which often do not provide the level of detail reviewed for thorough analysis of outcomes. Of concern is also the moderate statistical heterogeneity observed in our meta-analysis. Finally, the majority of studies exhibited an inadequate follow-up duration; a followup of at least 6-9 months is prudent for reliable and accurate assessment of renal recovery and the total duration of dialytic treatment.
Given the limited number and varying quality of studies in this field, we can draw only some cautious conclusions. In the future, it is recommended that authors randomize their patients to RRT modalities and that they follow up their patients for longer periods of time.
CONCLUSION
Renal recovery, days to renal recovery, number of treatments required for each dialysis modality and haemodynamic instability were not significantly different between the CRRT and SLED treatment groups. Based on these data, it is reasonable to conclude that these two modalities of renal replacement do not produce different outcomes in adults with shock and Renal recovery with SLED vs CRRT AKI. The overall risk of mortality was reduced in patients receiving SLED; however, this result was effectively lost when only RCT were used for sensitivity analysis indicating that original meta-analysis results may be due to unreported complications and potentially selection bias. Given the short follow up time of these patients and limitations of our systematic review, we must also be careful about drawing unequivocal conclusions regarding differences in renal recovery with currently available modes of renal replacement modalities.
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